NHC-40099-49473
4 vaccinations
2 coded responses
43 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 133 / NY
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-02-01
Registered in v-safe
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
-
2021-02-18
Dose 2 — Pfizer-BioNTech
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-03-05
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-05-20
- 2021-08-19
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
-
2022-04-02
Survey response — 6 months, dose 3MedDRA: COVID-19, Postpartum state — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Just had a baby and was diagnosed with COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-04-06
Call successfulParticipant prefers to complete VAERS report online
- 2022-10-02
-
2022-10-16
Dose 4 — Pfizer-BioNTech
-
2022-10-18
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2022-10-19
Survey response — days 1–6 daily, dose 4MedDRA: Cough — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend schoolFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-10-21
- 2022-10-23
- 2022-11-08
- 2022-11-13
- 2022-11-20
- 2022-11-27
- 2023-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-18 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-10-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 3
Symptoms: Just had a baby and was diagnosed with COVID
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Postpartum state | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release